Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Itti

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 22, 2016
Brain <sup>18</sup>F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic MyofascitisAxel Van Der Gucht, Mehdi Aoun Sebaiti, Eric Guedj, et al.
Journal of the American Heart Association|June 21, 2024
Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac AmyloidosisMohamed-Salah Annabi, Rasmus Carter-Storch, Amira Zaroui, et al.
ESC Heart Failure|July 18, 2024
Phenotype and prognostic factors in geriatric and non-geriatric patients with transthyretin cardiomyopathyEugenia Volpentesta, Mounira Kharoubi, Cristiano Donadio, et al.
JACC. Cardiovascular Imaging|May 25, 2023
Deep Learning on Bone Scintigraphy to Detect Abnormal Cardiac Uptake at Risk of Cardiac AmyloidosisMarc-Antoine Delbarre, François Girardon, Lucien Roquette, et al.
EJNMMI Research|May 27, 2024
Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective studyDavid Morland, Lukshe Kanagaratnam, Fabrice Hubelé, et al.
Hemasphere|January 30, 2023
Baseline <sup>18</sup>F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective StudyDavid Morland, Lukshe Kanagaratnam, Fabrice Hubelé, et al.
Leukemia & Lymphoma|March 25, 2021
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantationClarisse Cazelles, Karim Belhadj, Hélène Vellemans, et al.
Blood Advances|April 12, 2018
Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphomaMarie-Hélène Delfau-Larue, Axel van der Gucht, Jehan Dupuis, et al.
Hepatology Communications|June 27, 2024
Selective internal radiation therapy for unresectable HCC: The SIRT downstaging studyHélène Regnault, Julia Chalaye, Athena Galetto-Pregliasco, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2020
Extracardiac soft tissue uptake, evidenced on early <sup>99m</sup>Tc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic valueNathan Malka, Mukedaisi Abulizi, Mounira Kharoubi, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 22, 2016
Brain <sup>18</sup>F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic MyofascitisAxel Van Der Gucht, Mehdi Aoun Sebaiti, Eric Guedj, et al.
Journal of the American Heart Association|June 21, 2024
Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac AmyloidosisMohamed-Salah Annabi, Rasmus Carter-Storch, Amira Zaroui, et al.
ESC Heart Failure|July 18, 2024
Phenotype and prognostic factors in geriatric and non-geriatric patients with transthyretin cardiomyopathyEugenia Volpentesta, Mounira Kharoubi, Cristiano Donadio, et al.
JACC. Cardiovascular Imaging|May 25, 2023
Deep Learning on Bone Scintigraphy to Detect Abnormal Cardiac Uptake at Risk of Cardiac AmyloidosisMarc-Antoine Delbarre, François Girardon, Lucien Roquette, et al.
EJNMMI Research|May 27, 2024
Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective studyDavid Morland, Lukshe Kanagaratnam, Fabrice Hubelé, et al.
Hemasphere|January 30, 2023
Baseline <sup>18</sup>F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective StudyDavid Morland, Lukshe Kanagaratnam, Fabrice Hubelé, et al.
Leukemia & Lymphoma|March 25, 2021
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantationClarisse Cazelles, Karim Belhadj, Hélène Vellemans, et al.
Blood Advances|April 12, 2018
Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphomaMarie-Hélène Delfau-Larue, Axel van der Gucht, Jehan Dupuis, et al.
Hepatology Communications|June 27, 2024
Selective internal radiation therapy for unresectable HCC: The SIRT downstaging studyHélène Regnault, Julia Chalaye, Athena Galetto-Pregliasco, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2020
Extracardiac soft tissue uptake, evidenced on early <sup>99m</sup>Tc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic valueNathan Malka, Mukedaisi Abulizi, Mounira Kharoubi, et al.
Pageof 15